Ismael Ali García

Statistics

Publications

Citations

217

H-Index

Active since

2018

Affiliations

Hospital Universitario Son Espases(Current)

Health Research Institute of the Balearic Islands

AstraZeneca (United Kingdom)

University of Nottingham

AstraZeneca (Spain)

Ismael Ali García is an author at Hospital Universitario Son Espases specializing in pharmacotherapy, pharmacotherapy for eosinophilic asthma, and pulmonary function testing.

ORCID

Publications per year

2018–2023

Publications

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Renaud Louis, Tim Harrison, Pascal Chanez et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 24 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

COPD phenotypes: differences in survival

Julio Hernández Vázquez, Ismael Ali García, Rodrigo Jiménez‐García et al. · International Journal of COPD · 2018 · 18 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

1–3 of 3